Concordance between abdominal scintigraphy using technetium-99m hexamethylpropylene amine oxime-labelled leucocytes and ileocolonoscopy in patients with spondyloarthropathies and without clinical evidence of inflammatory bowel disease

Rheumatology

Volumn 38, Issue 6, 1999, Pages 543-546

  El Maghraoui, A ^a   Dougados, M ^a   Freneaux, E ^a   Chaussade, S ^a   Amor, B ^a   Breban, M ^a,b  

^a René Descartes University ^*  (France)

^b INSERM   (France)

Author keywords

Ileocolonoscopy; Inflammatory bowel disease; Scintigraphy; Spondyloarthropathy

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ABDOMINAL SCINTISCANNING; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DISEASE DURATION; ENTERITIS; FEMALE; HUMAN; ILEUM; INFLAMMATION; LEUKOCYTE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REACTIVE ARTHRITIS; SPONDYLOARTHROPATHY;

ABDOMEN; ADOLESCENT; ADULT; COLONOSCOPY; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKOCYTES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIONUCLIDE IMAGING; REPRODUCIBILITY OF RESULTS; SPONDYLITIS, ANKYLOSING; TECHNETIUM TC 99M EXAMETAZIME;

EID: 0032744942     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.6.543     Document Type: Article

References (14)

1. Dougados M, Alemanni M, Tulliez M, Abadia R, Kahan A, Delrieu F et al. Iléocoloscopie systématique au cours des spondyloarthropathies séronégatives. Rev Rhum 1987;54:279-83.
2. De Vos M, Cuvelier C, Mielants H, Veys E, Barbier F, Elewaut A. Ileocolonoscopy in seronegative spondylarthropathy. Gastroenterology 1989;96:339-44.
3. Mielants H, Veys EM, Goemaere S, Goethals K, Cuvelier C, De Vos M. Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study. J Rheumatol 1991;18:1542-51.
4. Leirisalo-Repo M, Turunen U, Stenman S, Helenius P, Seppälä K. High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum 1994; 37:23-31.
5. Lee YH, Ji JD, Kim JS, Bak YT, Lee CH, Kim CH et al. Ileocolonoscopic and histologic studies of Korean patients with ankylosing spondylitis. Scand J Rheumatol 1997; 26:473-6.
6. Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJF, Chadwick VS. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology 1986;90:1121-8.
7. 99mTc-HMPAO labelled leucocytes in patients with seronegative spondylarthropathies without clinical evidence of inflammatory bowel disease. Eur J Nucl Med 1996;23:243-6.
8. Alonso JC, Lopez-Longo FJ, Lampreave JL, Gonzalez CM, Gonzalez M, Almoguera I et al. Different abdominal scintigraphy pattern in patients with ulcerative colitis, Crohn's disease and seronegative spondylarthropathies. Br J Rheumatol 1995;34:946-50.
9. Dougados M, van der Linden S, Juhlin R, Huitfeld B, Amor B, Calin A et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
10. Mielants H, Veys EM, De Vos M, Cuvelier C, Goemaere S, De Clercq L et al. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects. J Rheumatol 1995;22:2266-72.
11. Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L et al. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol 1995;22:2273-8.
12. Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L et al. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol 1995;22:2279-84.
13. Leirisalo-Repo M, Repo H. Gut and spondyloarthropathies. Rheum Dis Clin North Am 1992;18:23-35.
14. Dougados M, van der Linden S, Leirsalo-Repo M, Huitfeldt B, Juhlin R, Veys E et al. Sulfasalazine in the treatment of spondylarthropathy: A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum 1995;38:618-27.